M.D., Ph.D., Senior Vice President, Translational Discovery & Chief Evangelist, Recursion, Recursion Pharmaceuticals
Dr. Alfa is Senior Vice President, Translational Discovery and Chief Evangelist at Recursion Pharma where he manages Early Commercial strategy for Recursion’s discovery portfolio and evangelism of Recursion’s mission to decode biology to radically improve lives. Prior to Recursion, Dr. Alfa worked trained in science and medicine at Stanford University where he also worked closely with biotech startups at Stanford affiliated accelerator StartX. He has made scientific contributions spanning Neurosciences, Metabolism, and Genetics and is passionate about Recursion’s approach to unlocking drug discovery for human genetics using AI.
AI and Data Sciences Showcase: Rercusion Pharma
Recursion combines experimental biology and bioinformatics with AI in a massively parallel system to efficiently identify treatments for diseases which can be modeled at the cellular level. The Recursion platform probes rich data from high-throughput automated screens for a number of indications, including rare disease, aging, inflammation, infectious disease, oncology, and diagnostics.